Literature DB >> 1465426

Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII).

Z Toossi1, J R Sedor, M A Mettler, B Everson, T Young, O D Ratnoff.   

Abstract

The results reported here indicate that activated species of Hageman factor (HF, factor XII), a protein that mediates blood clotting, fibrinolysis, and activation of the complement cascade, induce elaboration of interleukin 1 (IL-1) by human monocytes. Augmentation of IL-1 production in mononuclear cell cultures was observed when HF was present along with lipopolysaccharide (LPS) but was not observed with HF alone. Furthermore, antiserum to HF abrogated the enhancement of IL-1 in cultures containing HF and LPS. Total IL-1 activity, which represents secreted and cell-associated IL-1, was enhanced in LPS-stimulated mononuclear cultures by HF. In the absence of LPS, the initial activation product of HF, HFa, which contains the serine protease enzyme activity and the surface-binding domains of the protein, induced IL-1 beta protein and mRNA. In the presence of LPS, the enzymatic moiety (HFf), which is also contained in HF and HFa, amplified IL-1 production. Induction and amplification of monocyte IL-1 by HF provides further evidence for establishing a role for HF in the acute-phase reaction and the cellular immune response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465426      PMCID: PMC50679          DOI: 10.1073/pnas.89.24.11969

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  PROBIT: a computer program analysis.

Authors:  R S Wallis
Journal:  J Immunol Methods       Date:  1991-12-15       Impact factor: 2.303

2.  Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin.

Authors:  K Matsushima; M Taguchi; E J Kovacs; H A Young; J J Oppenheim
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

3.  Interleukin-1 induces interleukin-6 production in peripheral blood monocytes.

Authors:  G Tosato; K D Jones
Journal:  Blood       Date:  1990-03-15       Impact factor: 22.113

Review 4.  Interleukin-1 and its biologically related cytokines.

Authors:  C A Dinarello
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

Review 5.  Surface-mediated reactions.

Authors:  O D Ratnoff; H Saito
Journal:  Curr Top Hematol       Date:  1979

6.  The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.

Authors:  S D Revak; C G Cochrane; J H Griffin
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

7.  Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself.

Authors:  R Schindler; J A Gelfand; C A Dinarello
Journal:  Blood       Date:  1990-10-15       Impact factor: 22.113

8.  The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis.

Authors:  H I Werber; S N Emancipator; M L Tykocinski; J R Sedor
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

9.  Amino acid sequence of human beta-factor XIIa.

Authors:  K Fujikawa; B A McMullen
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

Review 10.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

View more
  20 in total

1.  Activated factor XI inhibits chemotaxis of polymorphonuclear leukocytes.

Authors:  Asako Itakura; Norah G Verbout; Kevin G Phillips; Robert H Insall; David Gailani; Erik I Tucker; Andras Gruber; Owen J T McCarty
Journal:  J Leukoc Biol       Date:  2011-08-01       Impact factor: 4.962

2.  Transforming growth factor-β1 induces expression of human coagulation factor XII via Smad3 and JNK signaling pathways in human lung fibroblasts.

Authors:  Ewa Jablonska; Philipp Markart; Dariusz Zakrzewicz; Klaus T Preissner; Malgorzata Wygrecka
Journal:  J Biol Chem       Date:  2010-02-08       Impact factor: 5.157

3.  High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes.

Authors:  Mohammad M Khan; Harlan N Bradford; Irma Isordia-Salas; Yuchuan Liu; Yi Wu; Ricardo G Espinola; Berhane Ghebrehiwet; Robert W Colman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-10       Impact factor: 8.311

4.  A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.

Authors:  Ricardo G Espinola; Audrey Uknis; Irma M Sainz; Irma Isordia-Salas; Robin Pixley; Raul DeLa Cadena; Walter Long; Alexis Agelan; John Gaughan; Albert Adam; Robert W Colman
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

5.  Hemostatic abnormalities and the severity of illness in patients at the onset of clinically defined sepsis. Possible indication of the degree of endothelial cell activation?

Authors:  B Leithäuser; F R Matthias; U Nicolai; R Voss
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

6.  A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study.

Authors:  Volker Pönitz; José W Govers-Riemslag; Hugo Ten Cate; Rene van Oerle; Trygve Brügger-Andersen; Heidi Grundt; Patrycja Næsgaard; David Pritchard; Alf I Larsen; Dennis W Nilsen
Journal:  Thromb J       Date:  2010-04-15

7.  Selective factor XIIa inhibition attenuates silent brain ischemia: application of molecular imaging targeting coagulation pathway.

Authors:  John W Chen; Jose-Luiz Figueiredo; Gregory R Wojtkiewicz; Cory Siegel; Yoshiko Iwamoto; Dong-Eog Kim; Marc W Nolte; Gerhard Dickneite; Ralph Weissleder; Matthias Nahrendorf
Journal:  JACC Cardiovasc Imaging       Date:  2012-11

8.  Factor XII and uPAR upregulate neutrophil functions to influence wound healing.

Authors:  Evi X Stavrou; Chao Fang; Kara L Bane; Andy T Long; Clément Naudin; Erdem Kucukal; Agharnan Gandhi; Adina Brett-Morris; Michele M Mumaw; Sudeh Izadmehr; Alona Merkulova; Cindy C Reynolds; Omar Alhalabi; Lalitha Nayak; Wen-Mei Yu; Cheng-Kui Qu; Howard J Meyerson; George R Dubyak; Umut A Gurkan; Marvin T Nieman; Anirban Sen Gupta; Thomas Renné; Alvin H Schmaier
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

Review 9.  Human plasma kallikrein-kinin system: physiological and biochemical parameters.

Authors:  J W Bryant; Z Shariat-Madar
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2009-07

10.  Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation.

Authors:  My-Linh Ngo; Fakhri Mahdi; Dhaval Kolte; Zia Shariat-Madar
Journal:  J Inflamm (Lond)       Date:  2009-01-27       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.